Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Shreyasee Das

40 indexed publications match this author name.

ORCID: 0000-0002-3988-6326
OpenAlex: https://openalex.org/A5121797777

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Pharmacology 13 Receptor Pharmacology 13 Clinical Trial 12 Depression 12 Toxicity 11 Safety 10 Mechanism of Action 9 Brain Imaging 7 Review Article 6 Adverse Events 5 Chronic Pain 5 Microdosing 5

Journals

RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia 7 Neuroscience Applied 3 BJPsych Open 2 Journal of Psychoactive Drugs 2 Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition 2 The British Journal of Psychiatry 1 MMWR. Morbidity and mortality weekly report 1 Progress in Neuro-Psychopharmacology and Biological Psychiatry 1

Publication history

Psilocybin therapy for adult females with anorexia nervosa: pilot study.The British Journal of Psychiatry · 2026-07-07 Pure psilocybin reduces reward-associated preference while mushroom extract shows transient exploratory effects in ratsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-04-30 Preclinical evaluation of psilocybin and related compounds: Inhibition of cytochrome P450 isoformsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-04-30 Cytochrome P450 Inhibition by Psilocybin and Psilocin: A Combined Molecular Dynamics and Enzymatic Screening StudyRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-04-30 Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUMBJPsych Open · 2026-04-30 Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.MMWR. Morbidity and mortality weekly report · 2026-04-08 Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trialBJPsych Open · 2026-02-15 Psychedelics in functional disorders: A scoping reviewProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-02-09 Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-04 An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomesNeuroscience Applied · 2025-12-31 A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy ParticipantsmedRxiv · 2025-12-22 Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trialJournal of Psychopharmacology · 2025-08-28 Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell ModelRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2024-12-31 Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depressionNeuroscience Applied · 2024-12-31 Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic SurveyJournal of Psychoactive Drugs · 2024-12-23 Neurochemical characterization of 5-HT2A R partial agonists with simultaneous PET-MRIJournal of Cerebral Blood Flow & Metabolism · 2024-11-28 Neuroimaging of Serotonergic and Psychedelic Agonist Drug Challenges in Non-Human PrimatesProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-11-25 Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of UseJournal of Psychoactive Drugs · 2024-11-05 Acute Effects of Psilocybin and Salvinorin-A on Functional ConnectivityProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-08-13 Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-AACS Chemical Neuroscience · 2024-06-24 Psychedelic Drugs: A Mind-expanding HallucinogensIndian Journal of Behavioural Sciences · 2024-03-21 Use of Psychedelics for Pain: A Scoping Review.Unknown journal · 2023-09-30 Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settingsFrontiers in Human Neuroscience · 2023-07-17 Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorderJournal of Psychiatric Research · 2023-03-27 Therapeutic potential of psilocybin: a promising agent in treating major depressive disorderAIDASCO Reviews · 2023-01-16 Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2022-12-31 Bedside to bench: the outlook for psychedelic research.Frontiers in pharmacology · 2022-12-31 Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16 Production and extraction of psilocybin and psilocin from Psilocybe spp. mushroomsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05 Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DADRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05 Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanismsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05 P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot studyEuropean Neuropsychopharmacology · 2021-11-30 Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in Psychiatry · 2021-10-19 These fungi drug cicadas with psilocybin or amphetamine to make them mate nonstopAccess Science · 2018-12-31 1.13 Microdosing of Hallucinogens Among College Students: Frequency, Correlates, and ConsequencesJournal of the American Academy of Child & Adolescent Psychiatry · 2018-09-30 Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogensbioRxiv · 2018-07-23 Challenges in Laboratory Detection of Unusual Substance Abuse: Issues with Magic Mushroom, Peyote Cactus, Khat, and Solvent Abuse.Unknown journal · 2016-08-31 [Trends in Abuse of Biogenic Drugs in Parts of Germany 2007-2013].Das Gesundheitswesen · 2016-06-13 Psilocybin: Historical and pharmacological perspective and current authorized researchRepositorio Universidad de Caldas · 2008-12-31 Chloroquine psychosis: a chemical psychosis?Unknown journal · 1981-10-31

Author directory